Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The ENETS network of accredited NET Centres of Excellence (CoE) across Europe was established to standardise and improve NET management.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Talbot D
Authors: Talbot D, Ferguson S, Mansoor W,
Keywords: Treatment pathways, Lung NET, Centre of Excellence, ENETS, Diagnostics,
Introduction: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare condition characterised by a generalised proliferation of pulmonary neuroendocrine cells within the respiratory epithelium. Little is known of its affects on pulmonary function both at the time of diagnosis and prospectively.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Barlow J
Authors: Barlow J, Ryan D, Mansoor W, Howell M, Clayton N,
Keywords: Neuroendocrine, Cell, Pulmonary, Function, Hyperplasia, Pulmonary function, Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, DIPNECH, Physiology,
Introduction: Knowledge of MANECs is limited
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Frizziero M, Wang X, Chakrabarty B, Mansoor W, Fulford P,
Keywords: manec, gastroinstestinal tract, overall survival,
Introduction: Limited treatment options exist for patients (pts) with advanced pulmonary carcinoids (PC). Capecitabine-temozolomide (CAPTEM) has demonstrated significant efficacy in pts with pancreatic neuroendocrine tumours. However, its role in PC remains unexplored.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Papaxoinis G
Authors: Papaxoinis G, McCallum L, Nasralla M, Nonaka D, Mansoor W,
Keywords: pulmonary carcinoids, capecitabine, temozolomide,
Introduction: It is recommended that people with cancer should be managed by an MDT and the outcomes should be communicated in a “timely manner”. However, it does not specify when this should be done, or by whom.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Rigby C
Authors: Rigby C, Mansoor W, Valle J, Hubner R, McNamara M,
Keywords: Patient communication MDT,